You searched for "x-vivo"

158 Products found

Too many choices? Use the filter option on the left to narrow your product listing.

Sort by:

Reliant™ Minigel TBE

Reliant^TM Gels, 4%, TBE, 2x12-well, 20 pack, with EtBr

Separation range: 8 bp to 1 kb
Catalog #: 54929

Sales unit: each

EA
Reliant™ Minigel TBE

Reliant^TM Gels, 4%, TBE, 8-well, 20 pack, with EtBr
Separation range: 8 bp to 1 kb
Catalog #: 54927

Sales unit: each

EA
Reliant™ Minigel TBE

Reliant^TM Gels, 4%, TBE, 20-well, 20 pack

Separation range: 8 bp to 1 kb
Catalog #: 54944

Sales unit: each

EA
Reliant™ Minigel TBE

Reliant^TM Gels, 4%, TBE, 20-well, 20 pack, with EtBr
Separation range: 8 bp to 1 kb
Catalog #: 54928

Sales unit: each

EA
Reliant™ Minigel TBE

Reliant^TM Gels, 1%, 2x12-well, 20 pack, with EtBr

Separation range: 300 bp to 8 kb

Catalog #: 54905

Sales unit: each

EA
Reliant™ Minigel TBE

Reliant^TM Precast Agarose Minigels TBE, 1%, 20-well, 20 pack, with EtBr
Separation range: 300 bp to 8 kb
Catalog #: 54907

Sales unit: each

EA
Reliant™ Minigel TAE

Reliant^TM Gels, 4%, TAE, 8-well, 20 pack, with EtBr

Separation range: 20 bp to 1 kb
Catalog #: 54925

Sales unit: each

EA
Reliant™ Minigel TAE

Reliant^TM Gels, 1%, TAE, 8-well, 20 pack, with EtBr

Separation range: 400 bp to 10 kb
Catalog #: 54803

Sales unit: each

EA
Reliant™ Minigel TBE

Reliant^TM Precast Agarose Minigel TBE,1%, 12-well, 20 pack, with EtBr
Ideal for routine DNA separations (300 bp to 8 kb)
Catalog #: 54820

Sales unit: each

EA
Reliant™ Precast Agarose Minigel TBE

Reliant^TM Precast Agarose Minigel TBE, 2%, 20-well, 20 pk, with EtBr
Separation range: 100 bp to 3 kb
Catalog #: 54939

Sales unit: each

EA
Reliant™ Minigel TBE

Reliant^TM Gels, 2%, TBE, 2x12-well, 20 pack, with EtBr
Separation range: 100 bp to 3 kb
Catalog #: 54813

Sales unit: each

EA
Reliant™ Minigel TAE

Reliant^TM Gels, 1%, TAE, no stain, 8-well, 20 pack

Separation range: 400 bp to 10 kb

Catalog #: 54801

Sales unit: each

EA
Fresh Human Leukopak - Mozobil/Neupogen® Mobilized (Day 6 Collection,Full Bag)
Fresh human leukopheresis product collected from peripheral blood mobilized with Neupogen(R) 10 ug/kg x 5, Mozobil 240 ug/kg x 2, Day 6 Collection, 1 Bag
Catalog #: 3Y-300D

Sales unit: each

EA
Fresh Human Leukopak - Mozobil/Neupogen® Mobilized (Day 5 Collection, Full Bag)
Fresh human leukopheresis product collected from peripheral blood mobilized with Neupogen(R) 10 ug/kg x 5, Mozobil 240 ug/kg x 2, Day 5 Collection, 1 Bag
Catalog #: 3Y-300A

Sales unit: each

EA
FlashGel^® Loading Dye (5X)

FlashGel^® Loading Dye (5X), 5 x 1 mL
Catalog #: 50462

Sales unit: each

EA
Fresh Human Leukopak - Neupogen® Mobilized (Day 5 Collection, Full Bag)
Fresh human leukopheresis product collected from peripheral blood mobilized with Neupogen(R) 10 mcg/kg/day x 5 days, 1 Bag, Day 5 Collection
Catalog #: 3Y-300

Sales unit: each

EA
Fresh Human Leukopak - Neupogen(R) Mobilized (Day 6 Collection, Full Bag)
Fresh human leukopheresis product collected from peripheral blood mobilized with Neupogen(R) 10 mcg/kg/day x 5 days, Second Collection, Day 6, 1 Bag
Catalog #: 3Y-300B

Sales unit: each

EA
PyroCell^® Monocyte Activation Test (MAT) Kit

PyroCell^® Monocyte Activation Test (MAT) Kit qualified for the monocyte activation test including 3 vials pooled PBMC (pMAT cells, 4 donors) as well as 3 vials of Cell Culture Medium Supplement for 3 x 96-well ELISA plates.
Catalog #: 00249735

Sales unit: kit

SA

Added to Your Shopping Cart

4
5
6
7
8(current)

You searched for "x-vivo"

754 Documents found

References - X-Vivo™
Overview of relevant references
TechSheet - X-VIVO™ Media Systems
Instructions for how to use the X-VIVO™ Media Series
TheraPEAK® X-VIVO® Hematopoietic Cell Culture Medium
Serum-free, GMP produced medium for cell therapy applications
Serum-free Media FFM Part Codes
2019 change of all RUO Media to FFM production overview of RUO and new FFM part codes (X-VIVO not included)
Primary Normal Human Cells and Media
In Vivo Relevance. In Vitro Results. Updated and revised cell content.
Non-viral Gene Modification for Ex-vivo Cell Therapy
In this interview our Director Transfection R&D discusses the advantages of non-viral transfection technologies for CRISPR- or transposon-based genetic modification cell and gene therapy.
TheraPEAK® T-VIVO® Cell Culture Medium – Overview
View or download this document for a comprehensive overview and learn how the chemically defined TheraPEAK® T-VIVO® Medium enhances T-cell culture and accelerates therapy development.
Terms and Conditions TheraPEAK T-VIVO Sample Request Program
4D-Nucleofector® LV Unit for Large-scale Transfection
Efficient, closed and scalable transfection for ex vivo cell and gene therapy applications
Instructions for Use - TheraPEAK® T-VIVO® Cell Culture Medium
Instructions for how to use the TheraPEAK® T-VIVO® Cell Culture Media Series
Developing Patient-specific Cell Therapy Manufacturing Processes
Poster presentation about patient-specific cellular therapies and their tremendous potential for being able to treat life threatening diseases where there are currently no cures.
NK Cell Assay using 3D Bioprinted Tumor Models
This white paper describes an ex vivo assay for NK cell killing activity in a 3D bioprinted cervical cancer tumor model.
A Novel Chemically Defined Medium Supports Superior Cross-platform T-cell Expansion
This poster showcases how the chemically defined TheraPEAK® T-VIVO® Medium supports superior T-cell expansion across different platforms.
Modeling a 3D respiratory model with the Quasi Vivo® QV600 Fluidic Cell Culture System
In this Technical Note, we provide detailed information of how the Quasi Vivo® QV600 System was set up for the ALI culture of normal human bronchial or small airway epithelial (NHBE, SAE) cells.
Non-Viral Methods for Ex vivo Cell and Gene Therapy – Is the Future Non-viral?
Learn from this interview about the types and benefits of non-viral methods for ex vivo cell and gene therapy as well as the readiness of electroporation-based technologies for use in GMP manufacturing.
A Novel In Vitro Liver Cell Culture Flow System Allowing Long-Term Metabolism and Hepatotoxicity Studies]
Manuscript published in Applied In Vitro Toxicology journal describes improvement of CYP450 phenotype of primary cryopreserved hepatocytes using Quasi Vivo® System
A Non-Viral Method for Modifying and Expanding Primary T Cells
Learn how Lonza’s Cocoon® Platform, 4D-Nucleofector® LV Unit and X-VIVO® 15 Medium are integrated to enable non-viral genetic modification and subsequent expansion of primary T cells in a functionally-closed, automated workflow.
Clonetics™ and Poietics™ Disease Cells
In Vivo Relevance. In Vitro Results. Product listings on Poster Six disease cell lines are identified:Airway, Skeletal Muscle,Adipose, Cardiac, Renal and Dermal
Fast-Track Development of an In Vitro 3D Lung/Immune Cell Model Using the Quasi Vivo® System
A Novel in vitro Liver Cell Culture Flow System Allowing Long-term Metabolism and Hepatotoxicity Studies
Lonza Scientific poster. Here we present an alternative in vitro model that is based on the long-term culture of PHH in the Quasi Vivo® QV900 flow system.

1(current)
2
3
4
5

You searched for "x-vivo"

5 Documents found

Product Availability by Store Location

Hours

Product Type

Application

Research Area

Primary Cell Type

Cell Line Type

Species

Formulation

Nucleofector™ Kit for

Instrument Type

Sensitivity

Throughput

Kit contains endotoxin

Result Output

Format

Accessory Type

Range

No. of Loads

Brand Name

Tissue Type

You searched for "x-vivo"

You searched for "x-vivo"

You searched for "x-vivo"